NCT00652795View on ClinicalTrials.gov

Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
To Determine Bioequivalence Under Fasting Conditions
Interventions
DRUG

Doxycycline Monohydrate

Tablets, 150 mg, single-dose

DRUG

Monodox

Capsules 50 mg (3 x 50 mg dose), single-dose

Trial Locations (1)

G1V 2K8

Anapharm, Sainte-Foy

Sponsors

Collaborators (1)

Anapharm
All Listed Sponsors
collaborator

Anapharm

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT00652795 - Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter